FDA fast-tracks Leap’s gastric cancer immunotherapyLeap Therapeutics will get a swift FDA review for its lead drug DKN-01 for a form of gastric Share XFDA fast-tracks Leap’s gastric cancer immunotherapyhttps://pharmaphorum.com/news/fda-fast-tracks-leaps-gastric-cancer-immunotherapy/
